PatientsLikeMe ™

all
Skip over navigation
Join Now (It's free!)

Already a member? Log in

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Brand Names: Tysabri

What is Natalizumab? Natalizumab is a monoclonal antibody given by infusion and used in the treatment of MS and Crohn's disease. It has been shown to slow progression and reduce relapses in MS. It is currently sold under the brand name Tysabri. Read more...Click to read more below

See more information, including instructions, precautions, side effects, and interactions.


Reasons Taken

378 patients in the community are taking or have taken Natalizumab.

Reason # Patients Percentage of patients
Slow my MS progress 315 86%
Other 25 6%
Stiffness/spasticity 6 1%
General health 5 1%
Fatigue 3 <1%
Don't know 2 <1%
disease-related symptoms 2 <1%
transfering 1 <1%
Imbalance when walking 1 <1%
Weakness in legs 1 <1%
Sensation 1 <1%
Pain 1 <1%

Dosages

Based on the patients currently taking Natalizumab.

Top 10 (Show all)

All (Show Top 10)

  0 g month 0 mg month 0 month 1 g month 1 mg month 1 month 4 mg month 5 mg month 15 mg month 20 mg month 25 mg month 30 mg month 50 mg month 100 mg month 200 mg month 300 mg month 1000 mg month 300 mg day
  2 Number of Patients: 2 184 Number of Patients: 184 27 Number of Patients: 27 1 Number of Patients: 1 2 Number of Patients: 2 5 Number of Patients: 5 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 2 Number of Patients: 2 1 Number of Patients: 1 3 Number of Patients: 3 4 Number of Patients: 4 80 Number of Patients: 80 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Natalizumab or how long patients were taking Natalizumab before stopping.

Currently taking Natalizumab

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
10
22
65
75
87
13

Stopped taking Natalizumab

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
6
10
6
8
4
0
Why Patients Stopped Taking Natalizumab (multiple reasons could be selected)
Reason # Patients Percentage of patients
Other 14 41% Other: 41%
Doctor's advice 12 35% Doctor's advice: 35%
Side effects too severe 11 32% Side effects too severe: 32%
Did not seem to work 6 18% Did not seem to work: 18%
Expense 1 3% Expense: 3%
Course of treatment ended 1 3% Course of treatment ended: 3%

Patient Reported Evaluations

Results from 17 patient evaluations. See the overall results and all individual evaluations.

Efficacy (Effect based on reason taken)

Major 24% 4
Moderate 24% 4
Slight 12% 2
None 18% 3
Can't tell 24% 4

Slow my MS progress

Side-effects (as an overall problem)

Severe 6% 1
Moderate 0% 0
Mild 59% 10
None 35% 6

Top reported side-effects include: tiredness, mild headache, Headaches

Summary results are based on 17 individual responses. For more information, see overall results for Adherence, Burden and Cost.

Individual Patient Reported Evaluations (2 of 17)

  • LadyMac
    Sensation: moderate
    Overall: mild
    Cognition: none
    Vision: none
    Speech: none
    Swallowing: mild
    Upper limb: mild
    Walking: moderate
    See profile
  • LadyMac
  • by LadyMac
    Aug 18, 2008
  • EfficacyCan't tell
  • Side-effectsNone
  • Slow my MS progress
Advice/Tips
Just be positive about the drug, that it's for you and what you need and want. Positive thinking can help more then one thinks. I'm looking forward to my next infusion next month. August '08 was my first infusion and I was happy with the TOUCH program. Was a very relaxing experience.

  • cureseeker
    Sensation: moderate
    Overall: mild
    Cognition: moderate
    Vision: moderate
    Speech: none
    Swallowing: none
    Upper limb: none
    Walking: moderate
    See profile
  • by cureseeker
    Aug 18, 2008
  • EfficacySlight
  • Side-effectsMild
  • Slow my MS progress

See all evaluation results for Natalizumab



Back to top